SCHEMBL8396925

SCHEMBL8396925

CCOC(=O)c1cnc(Cc2ccc(Cl)c(Cl)c2)nc1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP4F2 P78329 1/20 0.47
▸ CYP4A11 Q02928 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ MAOB P27338 1/20 0.46
▸ TSHR P16473 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ PTGES O14684 1/20 0.44
▸ ALOX5 P09917 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ KMT2A Q03164 3/20 0.43
▸ MAPT P10636 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ HPGD P15428 2/20 0.43
▸ GAA P10253 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ GFER P55789 1/20 0.42
▸ FOS P01100 1/20 0.42
▸ JUN P05412 1/20 0.42
▸ NFKB1 P19838 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399290 0.89 ALDH1A1 (0.49) CYP4F2CYP4A11CYP1A2MAOBTSHR
SCHEMBL8395191 0.84 FOS (0.48) CYP4F2CYP4A11CYP1A2MAOBTSHR
SCHEMBL8396996 0.82 NFKB1 (0.58) CYP1A2TSHRSMN1; SMN2ALDH1A1KDM4E
SCHEMBL1900971 0.77 NFKB1 (0.52) TSHRSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL31379759 0.74 ALDH1A1 (0.51) TSHRSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL762026 0.74 ALDH1A1 (0.51) TSHRSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL18187548 0.73 HSP90AA1 (0.45) TSHRSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL29442850 0.73 HSP90AA1 (0.45) TSHRSMN1; SMN2ALDH1A1KDM4EKMT2A
SCHEMBL10998466 0.73 HTR6 (0.44) TSHRALDH1A1MAPTHTTTDP1
SCHEMBL5111648 0.73 CYP1A2 (0.53) CYP4F2CYP4A11CYP1A2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 — — US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 — — WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 — — WO disclosed
Send feedback